The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats
- 23 November 2004
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 371 (2-3), 167-170
- https://doi.org/10.1016/j.neulet.2004.08.061
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effectNeuroscience Letters, 2004
- Topical cannabinoid antinociception: synergy with spinal sitesPain, 2003
- The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic painBritish Journal of Pharmacology, 2001
- Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the ratPain, 1999
- Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the ratPain, 1999
- Dose-response relationship of opioids in nociceptive and neuropathic postoperative painPain, 1998
- Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocainePain, 1996
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994
- Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic painPain, 1993
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980